Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)

Market Cap	30.97M +29.4%
Revenue (ttm)	16.32M -4.0%
Net Income	2.03M -36.7%
EPS	0.21 -38.7%
Shares Out	9.50M
PE Ratio	15.28
Forward PE	n/a
Dividend	0.19 (5.97%)
Ex-Dividend Date	Apr 16, 2026

Volume	150
Average Volume	2,348
Open	3.260
Previous Close	3.200
Day's Range	3.260 - 3.260
52-Week Range	2.810 - 3.550
Beta	n/a
RSI	52.10
Earnings Date	Mar 19, 2026

About ASE:HPIC

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

• Founded: 1994
• Employees: 246
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: HPIC

Financial Performance

In 2025, ASE:HPIC's revenue was 17.11 million, an increase of 2.39% compared to the previous year's 16.71 million. Earnings were 2.31 million, a decrease of -25.29%.